Correction: Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma.

Hose D, Ray S, Rößler S, Thormann U, Schnettler R, de Veirman K, Khassawna TE, Heiss C, Hild A, Zahner D, Alagboso F, Henss A, Beck S, Emde-Rajaratnam M, Burhenne J, Bamberger J, Menu E, de Bruyne E, Gelinsky M, Kampschulte M, Rohnke M, Wenisch S, Vanderkerken K, Hanke T, Seckinger A, Alt V.

Open source

DOI: 10.1186/s13045-025-01663-9
Published: 2025-01-24
Container: J Hematol Oncol
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13045-025-01663-9,
  title = {Correction: Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma.},
  author = {Hose D and  Ray S and  Rößler S and  Thormann U and  Schnettler R and  de Veirman K and  Khassawna TE and  Heiss C and  Hild A and  Zahner D and  Alagboso F and  Henss A and  Beck S and  Emde-Rajaratnam M and  Burhenne J and  Bamberger J and  Menu E and  de Bruyne E and  Gelinsky M and  Kampschulte M and  Rohnke M and  Wenisch S and  Vanderkerken K and  Hanke T and  Seckinger A and  Alt V.},
  year = {2025},
  journal = {J Hematol Oncol},
  doi = {10.1186/s13045-025-01663-9},
  url = {https://doi.org/10.1186/s13045-025-01663-9}
}

RIS

TY  - JOUR
TI  - Correction: Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma.
AU  - Hose D
AU  -  Ray S
AU  -  Rößler S
AU  -  Thormann U
AU  -  Schnettler R
AU  -  de Veirman K
AU  -  Khassawna TE
AU  -  Heiss C
AU  -  Hild A
AU  -  Zahner D
AU  -  Alagboso F
AU  -  Henss A
AU  -  Beck S
AU  -  Emde-Rajaratnam M
AU  -  Burhenne J
AU  -  Bamberger J
AU  -  Menu E
AU  -  de Bruyne E
AU  -  Gelinsky M
AU  -  Kampschulte M
AU  -  Rohnke M
AU  -  Wenisch S
AU  -  Vanderkerken K
AU  -  Hanke T
AU  -  Seckinger A
AU  -  Alt V.
PY  - 2025
JO  - J Hematol Oncol
DO  - 10.1186/s13045-025-01663-9
UR  - https://doi.org/10.1186/s13045-025-01663-9
ER  -

APA

D, H., S, R., S, R., U, T., R, S., K, D. V., TE, K., C, H., A, H., D, Z., F, A., A, H., S, B., M, E., J, B., J, B., E, M., E, D. B., M, G., M, K., M, R., S, W., K, V., T, H., A, S., & V., A. (2025). Correction: Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma.. J Hematol Oncol. https://doi.org/10.1186/s13045-025-01663-9

Source records

europe-pmc · retrieved 2026-09-25T23:53:56.692Z
doaj · retrieved 2026-09-25T23:53:56.698Z